Medication info
Rokatang 100 mg (Losartan Potassium)

Rokatang 100 mg (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›100mg / 1 tablet
Manufacturer / importer
Huons Co., Ltd.
Appearance
White, droplet-shaped film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201309883 · Approved 2013.10.24 · Insurance code 670606660

Summary

Main use
Treatment of hypertension and nephropathy in patients with type 2 diabetes accompanied by hypertension
Who takes it
Adults · Children
Adult dose
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension Adults The recommended initial and maintenance dose is losartan potassium 50 mg orally once daily. The maximum blood pressure-lowering effect is reached 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in 2 divided doses, or the dose may be increased to 100 mg once daily if necessary. If blood pressure is not controlled with this medicine alone, it may be administered with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed when administered with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used blood glucose-lowering agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations Elderly patients No adjustment of the initial dose is necessary in elderly patients 75 years of age or younger. For elderly patients over 75 years of age, an initial dose of 25 mg once daily is recommended. Patients with renal impairment Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients receiving dialysis: An initial dose of 25 mg once daily is recommended. Patients with reduced intravascular effective blood volume For patients who may have reduced intravascular effective blood volume (e.g., patients receiving diuretic treatment), an initial dose of 25 mg once daily is recommended (see Precautions for Use). Patients with hepatic impairment Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents 6 years of age and older who weigh 20 kg or more and less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg once daily; it may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents 6 years of age and older who weigh 50 kg or more: The usual recommended dose is 50 mg once daily; it may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate less than 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Ingredients

Manufacturer
Huons Co., Ltd.

Efficacy & effects

Treatment of hypertension and nephropathy in patients with type 2 diabetes accompanied by hypertension

  • Hypertension
  • kidney disease in patients with type 2 diabetes
View approved original text

This medication is used to lower blood pressure in patients with hypertension and helps prevent or treat kidney disease, particularly in patients with type 2 diabetes. By controlling blood pressure, it reduces the strain on the heart and kidneys, lowering the risk of complications. Therefore, it is effective in preventing cardiovascular diseases and kidney disease associated with hypertension.

How to take

Adult dose

This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension Adults The recommended initial and maintenance dose is losartan potassium 50 mg orally once daily. The maximum blood pressure-lowering effect is reached 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in 2 divided doses, or the dose may be increased to 100 mg once daily if necessary. If blood pressure is not controlled with this medicine alone, it may be administered with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed when administered with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used blood glucose-lowering agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations Elderly patients No adjustment of the initial dose is necessary in elderly patients 75 years of age or younger. For elderly patients over 75 years of age, an initial dose of 25 mg once daily is recommended. Patients with renal impairment Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients receiving dialysis: An initial dose of 25 mg once daily is recommended. Patients with reduced intravascular effective blood volume For patients who may have reduced intravascular effective blood volume (e.g., patients receiving diuretic treatment), an initial dose of 25 mg once daily is recommended (see Precautions for Use). Patients with hepatic impairment Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents 6 years of age and older who weigh 20 kg or more and less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg once daily; it may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents 6 years of age and older who weigh 50 kg or more: The usual recommended dose is 50 mg once daily; it may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate less than 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Precautions

This drug can cause serious harm to the fetus when taken during pregnancy, especially during the second and third trimesters, so women who are pregnant or may become pregnant should not use it. Patients with severely impaired liver function or genetic lactose intolerance should not take this medication. Caution is required when using this drug in certain populations, such as the elderly, patients with impaired kidney function, and those with hyperkalemia, as there is a risk of excessively low blood pressure. Side effects such as dizziness, headache, muscle cramps, and indigestion may occur while taking this medication, and in rare cases, angioedema or severe liver dysfunction may occur, so if any abnormal symptoms appear, immediate consultation with a healthcare professional is needed. Interactions may occur when taken with other medications, especially with potassium-sparing diuretics or potassium supplements, and non-steroidal anti-inflammatory drugs (NSAIDs). This drug may affect kidney function, so patients with renal disease need regular blood tests and kidney function monitoring. During treatment, blood pressure changes should be monitored regularly, and if symptoms of hypotension appear, healthcare professionals should be notified immediately. Women who are pregnant or planning to become pregnant should consult a doctor before taking this medication, and it is advisable for breastfeeding women to avoid taking it. Children, especially those under 6 years of age, or children with severely impaired kidney function should not take this medication. In case of overdose, hypotension and arrhythmias may occur, so it is crucial to adhere strictly to the prescribed dosage and visit a medical institution in case of overdose. This medication must be stored in a secure place out of reach of children and it is advisable not to transfer it to another container.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • death
  • muscle spasm
  • low back pain
  • leg pain
  • dizziness
  • congestion
Show 124 more
  • upper respiratory tract infection
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorder
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness/fatigue
  • edema/swelling
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm peeling
  • hemolysis
  • facial swelling
  • fever
  • orthostatic effect
  • fainting
  • angina pectoris
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • loss of appetite
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • arm pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory reduction
  • decreased libido
  • memory impairment
  • migraine
  • neurohyperesthesia
  • sensory disturbance
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • hypersomnia
  • tremor
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • nosebleed
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • flushing
  • photodermatitis
  • itching
  • rash
  • sweating
  • urticaria
  • blurred vision
  • ocular burning and pain
  • conjunctivitis
  • taste disturbance
  • tinnitus
  • vision loss
  • erectile dysfunction
  • nocturia
  • frequent urination
  • urethral infection
  • vascular edema
  • vasculitis
  • anaphylaxis-like syndrome
  • abnormal liver function
  • hepatitis
  • intestinal vascular edema
  • malaise
  • thrombocytopenia
  • myalgia
  • weakness
  • elevated creatine kinase
  • rhabdomyolysis
  • taste disturbance
  • dry cough
  • erythroderma
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • fainting
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular ectopic beats
  • atrial fibrillation
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly closed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1°C and 30°C.

Appearance and packaging

Appearance

White, droplet-shaped film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.